Aconitic acid - Compound Card

Aconitic acid

Select a section from the left sidebar

Aconitic acid

Structure
Zoomed Structure
  • Family: Plantae - Dracaenaceae
  • Kingdom: Plantae
  • Class: Tricarboxylic Acid
Canonical Smiles OC(=O)C/C(=C\C(=O)O)/C(=O)O
InChI InChI=1S/C6H6O6/c7-4(8)1-3(6(11)12)2-5(9)10/h1H,2H2,(H,7,8)(H,9,10)(H,11,12)/b3-1+
InChIKey GTZCVFVGUGFEME-HNQUOIGGSA-N
Formula C6H6O6
HBA 3
HBD 3
MW 174.11
Rotatable Bonds 4
TPSA 111.9
LogP -0.44
Number Rings 0
Number Aromatic Rings 0
Heavy Atom Count 12
Formal Charge 0
Fraction CSP3 0.17
Exact Mass 174.02
Number of Lipinski Rule Violations 0
# Species Family Kingdom NCBI Taxonomy ID
1 Sansevieria trifasciata Dracaenaceae Plantae 39534

Showing of synonyms

  • Tchegnitegni BT, Teponno RB, et al. (2017). A dihydrochalcone derivative and further steroidal saponins from Sansevieria trifasciata Prain.. Zeitschrift fur Naturforschung. C, Journal of biosciences,2017, 72(11-12), 477-482. [View] [PubMed]
Pubchem: 444212
Kegg Ligand: C02341
Chebi: 32806
Nmrshiftdb2: 60021715
Metabolights: MTBLC32806
Bindingdb: 50036212
CPRiL: 83196

No scaffolds available.

No bioactivities available.

Absorption

Caco-2 (logPapp)
-5.9
Human Oral Bioavailability 20%
Bioavailable
Human Intestinal Absorption
Absorbed
Madin-Darby Canine Kidney
-5.12
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-3.47

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
-0.09
Plasma Protein Binding
14.26
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
-1.02
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Safe
Bioconcentration Factor
0.88
Biodegradation
Toxic
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Toxic
Eye Irritation
Toxic
Maximum Tolerated Dose
1.95
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
3.68
Micronucleos
Safe
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
3.3
Rat (Acute)
1.9
Rat (Chronic Oral)
2.48
Fathead Minnow
3.69
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
315.97
Hydration Free Energy
-7.56
Log(D) at pH=7.4
-5.17
Log(P)
-0.27
Log S
-0.11
Log(Vapor Pressure)
-7.01
Melting Point
185.62
pKa Acid
2.44
pKa Basic
9.57
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
RNA-directed RNA polymerase P11124 RDRP_BPPH6 Pseudomonas phage phi6 3 0.8811
Geranyl diphosphate synthase large subunit Q9SBR3 Q9SBR3_MENPI Mentha piperita 3 0.8108
Farnesyl pyrophosphate synthase P14324 FPPS_HUMAN Homo sapiens 3 0.7540
N-acetylglutamate synthase, mitochondrial Q8N159 NAGS_HUMAN Homo sapiens 3 0.7303
Pyridoxal kinase, putative C4LVZ4 C4LVZ4_ENTHI Entamoeba histolytica 3 0.7066

Download SDF